Vasostatin I (CgA 17-76) vasoconstricts rat splanchnic vascular bed but does not affect central cardiovascular function

Autonomic Neuroscience: Basic and Clinical

Volumn 166, Issue 1-2, 2012, Pages 22-28

  Rahman, Ahmed A ^a,b   Shahid, Israt Z ^a,b   Fong, Angelina Y ^a   Hammond, Andrew M ^a   Pilowsky, Paul M ^a  

^a MACQUARIE UNIVERSITY   (Australia)

^b KHULNA UNIVERSITY   (Bangladesh)

Author keywords

Phrenic nerve discharge; Rat mesenteric artery; Reflex; Sympathetic nerve activity; Vasostatin I

Indexed keywords

CHROMOGRANIN A; NORADRENALIN; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; URETHAN; VASOSTATIN 1; PEPTIDE FRAGMENT; VASOCONSTRICTOR AGENT; VASOSTATIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY FUNCTION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CHEMORECEPTOR REFLEX; CONTROLLED STUDY; DOSE RESPONSE; HEART MUSCLE CONTRACTILITY; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; MICROINJECTION; NONHUMAN; PHRENIC NERVE; PRESSORECEPTOR; PRIORITY JOURNAL; RAT; SPLANCHNIC BLOOD FLOW; SPRAGUE DAWLEY RAT; VAGOTOMY; VASOCONSTRICTION; ADRENERGIC NERVE; ANIMAL; DRUG EFFECT; METHODOLOGY; PHYSIOLOGY; RESPIRATORY FUNCTION;

ADRENERGIC FIBERS; ANIMALS; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; CHROMOGRANIN A; MALE; MICROINJECTIONS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY PHYSIOLOGICAL PROCESSES; SPLANCHNIC CIRCULATION; VASOCONSTRICTOR AGENTS;

EID: 84855935927     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2011.08.023     Document Type: Article

References (39)

1. Aardal S., Helle K.B. The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels. Regul. Pept. 1992, 41:9-18.
2. Aardal S., Helle K.B., Elsayed S., Reed R.K., Serck-Hanssen G. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J. Neuroendocrinol. 1993, 5:405-412.
3. Abbott S.B.G., Pilowsky P.M. Galanin microinjection into rostral ventrolateral medulla of the rat is hypotensive and attenuates sympathetic chemoreflex. Am. J. Physiol. 2009, 296:R1019-R1026.
4. Amato A., Corti A., Serio R., Mulè F. Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-1) on the spontaneous contractions of rat proximal colon. Regul. Pept. 2005, 130:42-47.
5. Angelone T., Quintieri A.M., Brar B.K., Limchaiyawat P.T., Tota B., Mahata S.K., Cerra M.C. The antihypertensive Chromogranin A peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. Endocrinology 2008, 149:4780-4793.
6. Banks P., Helle K. The release of protein from the stimulated adrenal medulla. Biochem. J. 1965, 97:40C-41C.
7. Brekke J.F., Osol G.J., Helle K.B. N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries. Regul. Pept. 2002, 105:93-100.
8. Cappello S., Angelone T., Tota B., Pagliaro P., Penna C., Rastaldo R., Corti A., Losano G., Cerra M.C. Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism. Am. J. Physiol. 2007, 293:H719-H727.
9. Cerra M.C., De Iuri L., Angelone T., Corti A., Tota B. Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart. Basic Res. Cardiol. 2006, 101:43-52.
10. 1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide. FASEB J. 2008, 22:3992-4004.
11. Coote J.H., Lewis D.I. The spinal organisation of the baroreceptor reflex. Clin. Exp. Hypertens. 1995, 17:295-311.
12. Gaede A.H., Pilowsky P.M. Catestatin in rat RVLM is sympathoexcitatory, increases barosensitivity, and attenuates chemosensitivity and the somatosympathetic reflex. Am. J. Physiol. 2010, 299:R1538-R1545.
13. Gaede A.H., Lung M.S., Pilowsky P.M. Catestatin attenuates the effects of intrathecal nicotine and isoproterenol. Brain Res. 2009, 1305:86-95.
14. Guyenet P.G. The sympathetic control of blood pressure. Nat. Rev. Neurosci. 2006, 7:335-346.
15. Helle K.B. The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions. Cardiovasc. Res. 2010, 85:9-16.
16. Hong Y., Henry J.L. Glutamate, NMDA and NMDA receptor antagonists: cardiovascular effects of intrathecal administration in the rat. Brain Res. 1992, 569:38-45.
17. Imbrogno S., Angelone T., Corti A., Adamo C., Helle K.B., Tota B. Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action. Gen. Comp. Endocrinol. 2004, 139:20-28.
18. Krassioukov A.V., Munoz D.G., Yang J.P., Weaver L.C. Effect of chromogranin A on central autonomic control of blood pressure. J. Auton. Nerv. Syst. 1994, 50:61-71.
19. Lewis D.I., Coote J.H. Baroreceptor-induced inhibition of sympathetic neurons by GABA acting at a spinal site. Am. J. Physiol. 1996, 270:H1885-H1892.
20. Logothetis D.E., Kurachi Y., Galper J. The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart. Nature 1987, 325:321-326.
21. Mahapatra N.R., O Connor D.T., Vaingankar S.M., Hikim A.P.S., Mahata M., Ray S., Staite E., Wu H., Gu Y., Dalton N., Kennedy B.P., Ziegler M.G., Ross J., Mahata S.K. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J. Clin. Invest. 2005, 115:1942-1952.
22. Makeham J.M., Goodchild A.K., Costin N.S., Pilowsky P.M. Hypercapnia selectively attenuates the somato-sympathetic reflex. Respir. Physiol. Neurobiol. 2004, 140:133-143.
23. Makeham J.M., Goodchild A.K., Pilowsky P.M. NK1 receptor activation in rat rostral ventrolateral medulla selectively attenuates somato-sympathetic reflex while antagonism attenuates sympathetic chemoreflex. Am. J. Physiol. 2005, 288:R1707-R1715.
24. Metz-Boutigue M.-H., Garcia-Sablone P., Hogue-Angeletti R., Aunis D. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur. J. Biochem. 1993, 217:247-257.
25. Miyawaki T., Goodchild A.K., Pilowsky P.M. Activation of mu-opioid receptors in rat ventrolateral medulla selectively blocks baroreceptor reflexes while activation of delta opioid receptors blocks somato-sympathetic reflexes. Neuroscience 2002, 109:133-144.
26. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 1977, 41:19-26.
27. Pilowsky P.M., Goodchild A.K. Baroreceptor reflex pathways and neurotransmitters: 10years on. J. Hypertens. 2002, 20:1675-1688.
28. Pilowsky P.M., Lung M.S., Spirovski D., McMullan S. Differential regulation of the central neural cardiorespiratory system by metabotropic neurotransmitters. Philos. Trans. R. Soc. B 2009, 364:2537-2552.
29. Rahman A.A., Shahid I.Z., Pilowsky P.M. Intrathecal neuromedin U induces biphasic effects on sympathetic vasomotor tone, increases respiratory drive and attenuates sympathetic reflexes in rat. Br. J. Pharmacol. 2011, 164:617-631.
30. Roatta S., Passatore M., Novello M., Colombo B., Dondossola E., Mohammed E., Losano G., Corti A., Helle K.B. The chromogranin A- derived N-terminal peptide vasostatin-I: in vivo effects on cardiovascular variables in the rabbit. Regul. Pept. 2011, 168:10-20.
31. Sahu B., Sonawane P., Mahapatra N. Chromogranin A: a novel susceptibility gene for essential hypertension. Cell. Mol. Life Sci. 2010, 67:861-874.
32. Shahid I.Z., Rahman A.A., Pilowsky P.M. Intrathecal orexin A increases sympathetic outflow and respiratory drive, enhances baroreflex sensitivity and blocks the somato-sympathetic reflex. Br. J. Pharmacol. 2011, 162:961-973.
33. Somogyi P., Hodgson A.J., DePotter R.W., Fischer-Colbrie R., Schober M., Winkler H., Chubb I.W. Chromogranin immunoreactivity in the central nervous system. Immunochemical characterisation, distribution and relationship to catecholamine and enkephalin pathways. Brain Res. 1984, 320:193-230.
34. Stornetta R.L., Morrison S.F., Ruggiero D.A., Reis D.J. Neurons of rostral ventrolateral medulla mediate somatic pressor reflex. Am. J. Physiol. 1989, 256:R448-R462.
35. Stridsberg M., Angeletti R., Helle K. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods. J. Endocrinol. 2000, 165:703-714.
36. Sun M.K., Reis D.J. Intrathecal kynurenate but not benextramine blocks hypoxic sympathoexcitation in chemodenervated anesthetized rats. J. Auton. Nerv. Syst. 1994, 47:141-150.
37. Tota B., Mazza R., Angelone T., Nullans G., Metz-Boutigue M.H., Aunis D., Helle K.B. Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart. Regul. Pept. 2003, 114:123-130.
38. Tota B., Angelone T., Mazza R., Cerrav M.C. The chromogranin A-derived vasostatins: new players in the endocrine heart. Curr. Med. Chem. 2008, 15:1444-1451.
39. Woulfe J., Deng D., Munoz D. Chromogranin A in the central nervous system of the rat: pan-neuronal expression of its mRNA and selective expression of the protein. Neuropeptides 1999, 33:285-300.